EPISODE · Apr 25, 2023 · 42 MIN
Ep 21: Andy Coravos and Ashoka Rajendra on Hyperspecialization in Pharma R&D and Digital Biomarkers
from Vital Signs with Jacob Effron and Nikhil Krishnan · host Redpoint Ventures
Jacob sits down with HumanFirst CEO Andy Coravos and Orchestra CEO Ashoka Rajendra to discuss at home data collection in trials, Andy being an EIR at the FDA, why Benchling has been so successful and more.
What this episode covers
Jacob sits down with HumanFirst CEO Andy Coravos and Orchestra CEO Ashoka Rajendra to discuss at home data collection in trials, Andy being an EIR at the FDA, why Benchling has been so successful and more.
NOW PLAYING
Ep 21: Andy Coravos and Ashoka Rajendra on Hyperspecialization in Pharma R&D and Digital Biomarkers
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m